Atorvastatin
![Atorvastatin Structure](CAS/GIF/134523-00-5.gif)
- CAS No.
- 134523-00-5
- Chemical Name:
- Atorvastatin
- Synonyms
- ATORVASTATIN CA;Atorvastatin (Subject to Patent free);ATORVASTATIN CALCIUM SALT;Atorvastatin acid;ATORVASTATIN DIPROTECTED;Atorvastatin CalciuM Tablets;(3r,5r)-7-[2-(4-fluorophenyl)-3-phenyl-4-(phenylcarbamoyl)-5-propan-2-yl-pyrrol-1-yl]-3,5-dihydroxy-heptanoic acid;Cardyl;025-83371857;Atrovastitne
- CBNumber:
- CB4239912
- Molecular Formula:
- C33H35FN2O5
- Molecular Weight:
- 558.65
- MOL File:
- 134523-00-5.mol
- MSDS File:
- SDS
- Modify Date:
- 2024/8/2 18:12:07
Melting point | 176-178°C |
---|---|
Boiling point | 722.2±60.0 °C(Predicted) |
Density | 1.23±0.1 g/cm3(Predicted) |
storage temp. | 2-8°C |
solubility | DMSO: 100 mg/mL (179.01 mM) |
pka | pKa 4.46(H2O t=30 Iuncontrolled) (Uncertain) |
form | Solid |
color | White to light yellow |
CAS DataBase Reference | 134523-00-5(CAS DataBase Reference) |
EPA Substance Registry System | 1H-Pyrrole-1-heptanoic acid, 2-(4-fluorophenyl)-?,?-dihydroxy-5-(1-methylethyl)-3-phenyl-4-[(phenylamino)carbonyl]-, (?R,?R)- (134523-00-5) |
SAFETY
Risk and Safety Statements
Symbol(GHS) | ![]() ![]() GHS03,GHS07 |
---|---|
Signal word | Warning |
Hazard statements | H272-H315-H319-H335 |
Precautionary statements | P221-P261-P264b-P271-P280-P302+P352-P304+P340-P305+P351+P338-P312-P362+P364-P370+P378r-P370+P380+P375-P380-P501c |
Hazard Codes | Xn |
Risk Statements | 20/21/22-36/37/38 |
Safety Statements | 26-36 |
HS Code | 35040000 |
Atorvastatin Chemical Properties,Uses,Production
Chemical Properties
white Crystalline powder
Uses
antihyperlipoproteimic;HMG-CoA reductase inhibition
General Description
Atorvastatin, [R-(R*,R*)]-2-(4-fluorophenyl)-b,d-dihydroxy-5-(1-methylethyl)-3-phenyl-4-[(phenylamino)carbonyl]-lH-pyrrole-1-heptanoic acid(Lipitor), also possesses the heptanoic acid side chain,which is critical for inhibition of HMG-CoA reductase.Although the side chain is less lipophilic than the lactoneform, the high amount of lipophilic substitution causes this agent to have a slightly higher level of CNS penetration thanpravastatin, resulting in a slight increase in CNS side effects.Even so, its CNS profile is much lower than that of lovastatin.Atorvastatin is marketed as a combination therapywith amlodipine under the trade name Norvasc for managementof high cholesterol and high blood pressure.
Atorvastatin Preparation Products And Raw materials
Raw materials
1of2
chevron_rightPreparation Products
Supplier | Tel | Country | ProdList | Advantage | Inquiry |
---|---|---|---|---|---|
CHEMXTREE STANDARDS | +919872732255 | Punjab, India | 96 | 58 | Inquiry |
OPULENT PHARMA | +91-9106692785 +91-9106692785 | Gujarat, India | 479 | 58 | Inquiry |
Anant Pharmaceuticals Pvt Ltd | +91-8550986868 +91-9485998001 | Haryana, India | 461 | 58 | Inquiry |
Vadivarhe Speciality Chemicals Limited | +91-9028832204 +91-9028832204 | Maharashtra, India | 38 | 58 | Inquiry |
GLP Pharma Standards | +91 9866074638 | Hyderabad, India | 1644 | 58 | Inquiry |
Evans Fine Chem | +91-9821340302 +91-9821340302 | Maharashtra, India | 286 | 58 | Inquiry |
Shree HariKrishna Pharmaceuticals | +91-9925611910 +91-9925611910 | Gujarat, India | 16 | 58 | Inquiry |
Sainor Life Sciences Pvt Ltd | +919542990009 | AndhraPradesh, India | 13 | 58 | Inquiry |
Svak Life Sciences | +91-9963463333 +91-9705383777 | Hyderabad, India | 101 | 58 | Inquiry |
Dayaram Pharma Chem | +91-9601766800 +91-9601766800 | Gujarat, India | 61 | 58 | Inquiry |
134523-00-5(Atorvastatin)Related Search:
1of4
chevron_right